NO | ផលិតផល | cas ទេ | សូចនាករគុណភាពសំខាន់ៗ | |||
ភាពបរិសុទ្ធ | អតិបរមា។ ដេលធេវី | សំណល់សារធាតុរំលាយសរុប | សមនើម | |||
1 | fmoc-β-ala-ala -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
2 | FMoc-D-Ala-D-Ala-Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
3 | fmoc-β-ala-d-ala-y | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
4 | FMoc-Arg (PBF) -ARG (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
5 | FMOC-β-Ala-alg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
6 | FMoc-D-Arg (PBF) -D-Arg (PBF) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
7 | FMOC-β-Ala-D-Arg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
8 | FMOC-Homoarg (PBF) -homooarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
9 | FMOC-β-Ala-homoarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
10 | fmoc-asn (trt) -asn (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
11 | fmoc-β-ala-asn (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
12 | FMOC-ASP (OTBU) -App (OTBU) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
13 | FMOC-β-Ala-Asp (OTBU) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
14 | FMOC-CYS (TRT) -CYS (TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
15 | fmoc-β-ala-cys (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
16 | FMOC-CYS (ACM) -CYS (ACM) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
17 | fmoc-β-ala-cys (acm) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
18 | fmoc-gln (trt) -gln (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
19 | fmoc-β-ala-gln (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
20 | FMoc-Glu (OTBU) -Glou (OTBU) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
21 | FMOC-β-Ala-Glu (OTBU) -oh.h2o | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
22 | fmoc-β-ala-gly-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
23 | FMOC-របស់គាត់ (TRT) -his (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
24 | fmoc-β-ala-ala (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
25 | FMOC-Ile-Ole-OO | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
26 | FMOC-β-Ala-le-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
27 | fmoc-leu-leu-yo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
28 | fmoc-β-ala-leu-yo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
29 | fmoc-d-leu-d-leu-oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
30 | FMOC-β-Ala-D-Leu-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
31 | FMOC-LYS (BOC) -lys (Boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
32 | FMOC-β-Ala-Lys (Boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
33 | FMOC-LYS (ALECH) -lys (ALOC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
34 | fmoc-β-ala-lys (ALACH) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
35 | FMOC- Met-Met - អូ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
36 | fmoc-β-met -h-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
37 | FMOC-Orn (Boc) -orn (Boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
38 | fmoc-β-ala-orn (boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
39 | fmoc-phe-phe-y | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
40 | fmoc-β-ala-phe-y | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
41 | fmoc-d-phe-d-phe-y | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
42 | FMOC-β-ala-d-phe-y | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
43 | FMoc-Pro-Oh Pro-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
44 | FMOC-β-Ala-Pro-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
45 | FMOC-SER (TBU) -Ser (TBU) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
46 | fmoc-β-ala-ser (tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
47 | FMOC-SER (TRT) -Ser (TRT) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
48 | fmoc-β-ala-sere (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
49 | FMOC-THR (TBU) - TBU (TUU) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
50 | fmoc-β-ala-tr (tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
51 | FMOC-TRP (BOC) -Trp (Boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
52 | fmoc-β-ala-trp (boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
53 | FMOC-D-TRP (BOC) -D-TRP (BOC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
54 | FMOC-β-Ala-D-TRP (BOC) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
55 | FMOC-TYR (TBU) -TYR (TBU) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
56 | fmoc-β-ala-tyr (tbu) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
57 | fmoc-d-tyr (et) -d-tyr (et) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
58 | fmoc-β-ala-d-tyr (et) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
59 | FMOC-TYR (ខ្ញុំ) -thtyr (ខ្ញុំ) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
60 | fmoc-β-ala-tyr (ខ្ញុំ) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
61 | FMOC-Val-Oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
62 | FMOC-β-ala-val-oo | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
63 | FMOC-D- Cit-D-D-CIT-OO | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
64 | FMOC-β-Ala-D-Cit-Oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
65 | FMOC-β-Ala-Dab-OO | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
66 | FMOC- (3- (2-naphththyl) -d-ala) 2 -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
67 | FMOC-β-Ala-3- (2-naphththyl) -d-ala-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
68 | FMOC- (3- (3- 3- Pyridinyl) -d-ala) 2 -h | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
69 | FMOC-β-Ala-3- (3-Pyridinyl) -d-ala-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
70 | FMOC- (4-chloro-d-phe) 2- អូ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
71 | FMOC-β-Ala-4-chloro-d-phe-y | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
72 | FMOC- (D-4APAH (TBUCBM) 2- អូ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
73 | FMOC-β-Ala-D-4APH (TBUCBM) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
74 | FMOC-AP (L-HOL) -APH (L-HOH) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
75 | FMOC-β-Ala-Ap (L-HOL) -OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
76 | FMoc-Lys (ipr, Boc) គឺ (អាយភីអា, បូក) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
77 | fmoc-β-ala-lys (ipr, boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
78 | fmoc-β-ala-aeea-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
79 | fmoc-aib-aib -h-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
80 | fmoc-β-ala-aib -h-oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
81 | FMoc-Arg-Oh OH | 91000-69-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
82 | H-ARG (PBF) -oh | 2001115-86-86-86-86-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
83 | FMoc-D-Arg-Oh OH | 130752-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
84 | HD-ARG (PBF) -oh | 200116-81-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
85 | FMOC-Homoarg-Oh.HCL | 208174-14-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
86 | H-Homoarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
87 | fmoc-d-homoarg -h of អូ | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
88 | HD-Homoarg (PBF) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
89 | fmoc-asn -h | 71989-16-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
90 | H-ASN (TRT) -oh | 132388-58-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
91 | fmoc-asp -ho | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
92 | H-ASP (OTBU) -oh | 3057-74-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
93 | FMOC-CYS-OO | 135248-89-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
94 | H-CYS (TRT) -oh | 2799/7/7/7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
95 | H-CYS (ACM) -oh.hcl | 28798-28-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
96 | fmoc-gln-oh | 71989-20-20-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
97 | H-GLN (TRT) -oh | 102747-84-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
98 | fmoc-glu-oo | 121343-82-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
99 | H-GLU (OTBU) -oh.h2o | 2419-56-9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
100 | fmoc-ho oh oh | 116611-64-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរ 101 | H-H-Her (Trt) -oh | 35146-32-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរទៅវិញន៍ 102 | boc-ho-oh | 17791-52-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
បីកុន | fmoc-lys -h | 105047-45-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរទៅវិញន៍នៈ | H-LYS (BOC) -oh | 2418-95-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
105 បីនាក់ | H-LYS (ALACO) -OH | 6298/3/9/9 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរ / រិយសង្កាម | fmoc-orn-o.hcl | ឆ្នាំ 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរទៅវិញន៍ 107 | H-orn (Boc) -oh | 13650-49-2-2 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយញដោយយរវ័យ 108 | FMOC-Ser-OO OH | 73724-45-5 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
ាប់បីហិប | h-ser (tbu) -oh | 18822-58-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
មយយ | h-sere (trt) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយយត | FMOC-OR-OH.H2O | 73731-37-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរទៅវិញន៍ | H-THR (TBU) -oh | 4378-13-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អយតដោ | fmoc-trp -h | 35737-15-6 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយញវិញ | H-TRP (BOC) -oh | 146645-63-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយញហេតុ | fmoc-d-trp -h | 86123-11-11-7 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយយ | HD-TRP (BOC) -oh | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយយតមនត់ | fmoc-tyr-oh អូ | 92954-90-0 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អយយ | H-TYR (TBU) -oh | 18822-59-8 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមនយយយយ 99 | FMoc-D-Tyr-Oh OH | 112883-29-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
120 | HD-TYR (et) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
121 | H-TYR (ខ្ញុំ) -oh.hcl | 67423-44-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
122 | fmoc-d-4APH (CBM) -oh | 324017-22-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរទៅវិញន៍ផ្លើរ | HD-4APH (TBUCBM) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
124 | fmoc-lys (ipr) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
អមយរផ្លើ | H-LYS (iPR, Boc) -oh | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
ការយកមកតុតាត់
Gustolex ផ្តល់នូវផលិតផលដែលមានគុណភាពខ្ពស់ប្រសិនបើគុណភាពផលិតផលត្រូវបានលើកឡើងដោយអតិថិជនក្នុងកំឡុងពេលដែលត្រូវការជាមួយភ័ស្តុតាងគ្រប់គ្រាន់យើងនឹងផ្តល់ការវិភាគនិងវាយតម្លៃដើម្បីកេះនីតិវិធីនៃសំណង។
ផលិតកម្ផ
សមត្ថភាពផលិតផលឱសថបានមកដល់សុន្ទរកថាថ្នាក់ទរសមត្ថភាពផលិតផលិតផលគីមីឈានដល់ 100 ធាម + សមត្ថភាពត្រូវបានបំពាក់យ៉ាងល្អដើម្បីបម្រើអតិថិជនទូទាំងពិភពលោក។
ស្រាវជ្រាវនិងអភិវឌ្ឍន៍
ជារៀងរាល់ឆ្នាំមានផែនការបង្កើតដោយក្រុម R & D ដើម្បីអភិវឌ្ឍផលិតផលថ្មីៗផ្សេងៗគ្នានៅពេលគោលដៅដែលបានកំណត់នោះសមាជិកទាំងអស់នៅក្នុងក្រុមនឹងត្រូវបន្តទទួលខុសត្រូវរបស់ខេភីនិងគោលនយោបាយលើកទឹកចិត្ត។